Search alternatives:
decrease lipids » decrease lipid (Expand search), increase lipid (Expand search), decreases liquid (Expand search)
decrease drugs » disease drugs (Expand search), decrease treg (Expand search), release drugs (Expand search)
drugs decrease » drugs increases (Expand search), drugs release (Expand search)
decrease of » decrease in (Expand search)
of decrease » or decrease (Expand search), not decrease (Expand search), of decree (Expand search)
decrease to » decreased to (Expand search), decrease toc (Expand search), decrease the (Expand search)
lipids are » lipids and (Expand search), lipids act (Expand search), lipids after (Expand search)
decrease lipids » decrease lipid (Expand search), increase lipid (Expand search), decreases liquid (Expand search)
decrease drugs » disease drugs (Expand search), decrease treg (Expand search), release drugs (Expand search)
drugs decrease » drugs increases (Expand search), drugs release (Expand search)
decrease of » decrease in (Expand search)
of decrease » or decrease (Expand search), not decrease (Expand search), of decree (Expand search)
decrease to » decreased to (Expand search), decrease toc (Expand search), decrease the (Expand search)
lipids are » lipids and (Expand search), lipids act (Expand search), lipids after (Expand search)
1
2
4
“... delivery in different diseases. Nanostructured lipid carriers (NLC) are composed of both solid and liquid...”
Access document
Access document
Article
5
“... interactions with drugs metabolized by CYP enzymes or the CYP3A4 substrate grapefruit juice. In clinical trials...”
Access document
Access document
Article
6
7
8
“.... Significant changes are observed at 2 [mu]M and expressed by a decrease of phosphatidylethanolamine (relative...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
9
10
11
12
“... agonist or antagonist responses depending on the target tissue and hormonal milieu. the drugs are being...”
Access document (1)
Access document (2)
Access document (1)
Access document (2)
Article
13
14
15
16
“... biodegradable and biocompatible profile, capacity to prevent chemical degradation of loaded drugs/actives and...”
Access document
Access document
Article
17
18
19
“... treatments, research and development of innovative therapies and new diagnostics are crucial to increase the...”
Access document
Access document
Article
20
“... functions regulated by GPCRs, these are main targets of existing drugs. During normal aging, alterations...”
Access document
Access document
Article